3 ms·

I agree with the last part of your statement, but not the first. By the time an effective vaccine is developed and run through human trials, most of the popula

I agree with the last part of your statement, but not the first. By the time an effective vaccine is developed and run through human trials, most of the population will already have gotten Covid, so it's not likely to be a savior moment. Additionally, given how many vaccine candidates are already in the pipeline, it's pretty likely there will be multiple options approved within a few months of each other. On a related note, if China wants to improve its STEM research prestige level, it needs to do something about the rampant fraud in research results that cause a lot of people to be highly skeptical of anything they publish.

nopinsight 7y ago
Many countries, esp in East Asia, have slowed COVID spread down a great deal. Vaccines will likely be invented before it penetrates the populations there. They are among the largest groups of graduate students, ie key research workforce, in the US. If a vaccine developed in East Asia is either cheaper, more scalable, or more effective, increased self-confidence would mean many top students will choose to pursue graduate studies at home instead of the US. This is in addition to fear of being discriminated against because of the pandemic. Given the number of top people in East Asia with strong quantitative skills, it would significantly shift research momentum to the east. https://www.oecd.org/pisa/PISA-results_ENGLISH.png https://www.oecd.org/pisa/PISA-results_ENGLISH.png